DualDur cell technology medium and preparation method was developed by a number of laboratory specialists to provide a reliable diagnosis for Lyme borreliosis.
The basic idea, dark-field microscopy has been used to investigate other spirochetes for over a century.
However, microscopy is not suitable to investigate Borrelia in untreated fresh blood. It was a long way to work out the medium and method until DualDur became a diagnostic method.
We carried out 40,000 investigations with DualDur, while carefully observing and recording clinical symptoms, and performing 110,000 serological tests to back up the diagnosis.
DualDur can be used in standard laboratory diagnostics as a complementary method. With the support of the European Commission’s Horizon 2020 programme, we have successfuly carried out clinical testing. DualDur with automated, artificial intelligence microscopy performed best in terms of sensitivity, and it was proven that DualDur can identify 96% of the patients suffering from Lyme borreliosis (PPV). First publication appeared, the method and the device were patented. Based on these results, IVD CE registration was achieved, and DualDur is available at several laboratories and doctors across Europe, samples are sent from 30+ countries.
